| Biologic Therapy |
1 |
1 |
| Breast Cancer |
0 |
0.9 |
| Palliative Care |
0 |
0.66 |
| Hand |
0 |
0.63 |
| Pedal |
0 |
0.51 |
| Cancer |
0 |
0.45 |
| Gastrointestinal Cancer |
0 |
0.4 |
| Supportive Care in Cancer |
0 |
0.36 |
| Breast |
0 |
0.23 |
| Osteoarthritis |
0 |
0.21 |
| Patient Safety |
0 |
0.21 |
| Adverse Effects |
0 |
0.11 |
| Palmar |
0 |
0.11 |
| Cerebrovascular Accident |
0 |
0.1 |
| Diarrhea |
0 |
0.1 |
| Tyrosine Kinase Inhibitor |
0 |
0.08 |
| Adherence |
0 |
0.06 |
| Blister |
0 |
0.06 |
| Chemotherapy |
0 |
0.06 |
| Generics |
0 |
0.06 |
| Hemorrhage |
0 |
0.06 |
| Indiana |
0 |
0.06 |
| Mucositis |
0 |
0.06 |
| Myelosuppression |
0 |
0.06 |
| Oncology Practice |
0 |
0.06 |
| Pennsylvania |
0 |
0.06 |
| Prostaglandin |
0 |
0.06 |
| Quality of Life |
0 |
0.06 |
| Tyrosine Kinase |
0 |
0.06 |
| Vascular Endothelial Growth Factor |
0 |
0.06 |